Glenn Noronha
Clearside Biomedical (United States)(US)BridgeBio (United States)(US)
Publications by Year
Research Areas
Retinal Diseases and Treatments, Chronic Myeloid Leukemia Treatments, Retinal and Optic Conditions, Myeloproliferative Neoplasms: Diagnosis and Treatment, Glaucoma and retinal disorders
Most-Cited Works
- → Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera(2008)381 cited
- → TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations(2007)282 cited
- → Molecular recognition in micelles: the roles of hydrogen bonding and hydrophobicity in adenine-thymine base-pairing in SDS micelles(1993)180 cited
- → Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis(2020)167 cited
- → An improved method for the synthesis of enantiomerically pure amino acid ester isocyanates(1992)157 cited
- → Suprachoroidal and Subretinal Injections of AAV Using Transscleral Microneedles for Retinal Gene Delivery in Nonhuman Primates(2020)134 cited